Key Performance
More- Earnings Score: N/A
- Momentum Score: 11
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Rosen Law Firm reminds investors of Nano-X Imaging Ltd. who purchased securities between March 31, 2025 and April 17, 2026 of the August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges defendants made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased operating expenses, and cash burn that necessitated restructuring.
08/01/2026, 10:05 AM • GlobeNewswire
Rosen Law Firm announces a securities class action lawsuit against Nano-X Imaging Ltd. (NNOX) for investors who purchased securities between March 31, 2025 and April 17, 2026. The lawsuit alleges that company defendants made false statements about operational efficiency improvements and product demand, while concealing manufacturing issues, operational misalignment, and significant cash burn. The deadline to join the class action is August 11, 2026.
08/01/2026, 10:05 AM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Microvast Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and the completion of facility expansions. Investors who purchased securities during the class period may be eligible for compensation.
07/28/2026, 5:47 PM • GlobeNewswire
Pomerantz LLP filed a class action lawsuit against Nano-X Imaging Ltd. and certain officers for alleged securities fraud. The lawsuit claims defendants made false statements about operational efficiency and demand, while the company was actually experiencing poor production alignment, increased expenses, and cash burn. The truth emerged on April 20, 2026, when Nano-X reported a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and announced its CFO's departure, causing the stock to fall 24.39%.
07/28/2026, 4:56 PM • GlobeNewswire
The Schall Law Firm is seeking investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about product demand and operational efficiency while suffering from poor customer alignment and increased cash burn.
07/24/2026, 9:57 AM • GlobeNewswire
Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Nano-X Imaging Ltd. (NNOX) for allegedly making false statements about operational efficiency and product demand. The lawsuit claims the company overstated gains while experiencing poor manufacturing alignment, increased operating expenses, and significant cash burn, requiring restructuring charges. The lead plaintiff deadline is August 11, 2026.
07/22/2026, 11:32 PM • GlobeNewswire
Pomerantz Law Firm has filed class action lawsuits against ADMA Biologics, Lucid Group, and Nano-X Imaging, alleging securities fraud and unlawful business practices. ADMA's stock declined significantly following a short report alleging channel stuffing and inflated revenue figures, with additional losses after a downgrade from Cantor Fitzgerald.
07/21/2026, 1:51 PM • GlobeNewswire
Pomerantz LLP has filed a class action lawsuit against Nano-X Imaging Ltd. and certain officers for alleged violations of federal securities laws. The lawsuit claims defendants made materially false statements about operational efficiency and demand, when in reality the company experienced poor production alignment, increased operating expenses, and significant cash burn. The truth emerged on April 20, 2026, when Nano-X announced a $17.5 million impairment charge related to restructuring its Korean manufacturing facility and a shift to outsourced production, causing the stock to fall 24.39%.
07/21/2026, 1:47 PM • GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Nano-X Imaging Ltd. Investors
The Portnoy Law Firm has announced a class action lawsuit on behalf of Nano-X Imaging Ltd. investors who purchased securities between March 31, 2025 and April 17, 2026. The complaint alleges that defendants overstated operational efficiency gains and product demand while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The truth emerged on April 20, 2026, when Nano-X reported a Q4 2025 net loss of $33.4 million, including a $17.5 million impairment charge related to restructuring at its Korean facility and a shift to outsourced production. The company's CFO also announced his resignation.
07/21/2026, 10:54 AM • GlobeNewswire
Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures. The lead plaintiff deadline is August 11, 2026.
07/19/2026, 11:05 PM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against GPGI, Inc. (formerly CompoSecure), Lucid Group, Inc., and Nano-X Imaging Ltd. on behalf of investors who suffered losses. The GPGI lawsuit alleges defendants made materially false statements regarding the Husky acquisition valuation and financial targets. Investors are encouraged to secure counsel before important deadlines.
07/16/2026, 8:28 PM • GlobeNewswire
Rosen Law Firm is reminding investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 of an important August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that necessitated restructuring.
07/16/2026, 7:51 PM • GlobeNewswire
A class action lawsuit has been filed against Nano-X Imaging Ltd. (NASDAQ: NNOX) alleging that company executives made materially false and misleading statements regarding operational efficiency and product demand. The complaint claims Nano-X overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses and cash burn. Investors who purchased securities between March 31, 2025 and April 17, 2026 are eligible to join the case, with a lead plaintiff deadline of August 11, 2026.
07/16/2026, 12:00 PM • GlobeNewswire
Nano-X Imaging Ltd. (NNOX) investors have until August 11, 2026, to file motions to become lead plaintiffs in a securities class action lawsuit. The action stems from a 24.39% single-day stock decline on April 20, 2026, following disclosure of a $17.5 million asset impairment and closure of the company's South Korean chip manufacturing facility. Lead plaintiffs will oversee litigation regarding alleged misrepresentations about manufacturing efficiency and product demand during the March 31, 2025 to April 17, 2026 period.
07/14/2026, 9:56 AM • GlobeNewswire
Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures.
07/13/2026, 4:56 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 07/31/2026
Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.